Handelsavisen
prelaunch
MP
MPPA.JK IDX (Jakarta) Food Retail & Distribution

Matahari Putra Prima Tbk PT

$52,00
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
0,00 %
Op margin
0,4 %
ROE
-13,5 %
Net margin
-1,5 %
Debt / equity
7,66
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Matahari Putra Prima Tbk PT operates in the food retail and distribution sector, generating revenue primarily through the sale of food and drug products to consumers.

Business. Matahari Putra Prima Tbk PT (MPPA.JK) is a food and drug retailer headquartered in Indonesia. The company operates within the Consumer Non-Cyclicals sector, specifically focusing on food retail and distribution activities. It is primarily listed on the Indonesia Stock Exchange (IDX). Detailed information regarding operating segments and geographic revenue mix is not available.

Classification92 %
SectorConsumer Non-Cyclicals
Business sectorFood & Drug Retailing
IndustryFood Retail & Distribution
ActivityFood & Drug Retailing
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-13,5 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning MPPA.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples · THIS SECTOR−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to MPPA.JK. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Matahari Putra Prima Tbk PT (MPPA.JK) is a food and drug retailer headquartered in Indonesia. The company operates within the Consumer Non-Cyclicals sector, specifically focusing on food retail and distribution activities. It is primarily listed on the Indonesia Stock Exchange (IDX). Detailed information regarding operating segments and geographic revenue mix is not available.

    Classification92 %
    SectorConsumer Non-Cyclicals
    Business sectorFood & Drug Retailing
    IndustryFood Retail & Distribution
    ActivityFood & Drug Retailing
    AI synthesis
    GENERATED

    Matahari Putra Prima Tbk PT has a highly leveraged capital structure, with a debt-to-equity ratio of 7.66, indicating a significant reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 0.75, suggesting that it may struggle to meet short-term obligations without additional financing. Despite this, the company reported positive operating cash flow of 173,010,000,000 IDR and free cash flow of 52,292,000,000 IDR, which provides some buffer for operational needs and debt servicing.

    Profitability metrics for the company are weak, with a return on equity of -0.1352 and a return on assets of -0.0079, both of which are negative, indicating that the company is not generating returns for its shareholders or effectively utilizing its assets. These figures are likely below the industry median for the Food Retail & Distribution sector, which typically expects positive returns to sustain operations and growth.

    The company's revenue is concentrated in the food and drug retailing segment, with no disclosed geographic diversification in the provided data. This concentration may expose the company to regional economic fluctuations and supply chain disruptions, which could impact its overall performance.

    The company's growth trajectory appears to be under pressure, with a net loss of 27,285,000,000 IDR reported in the latest financial snapshot. While the company has positive operating cash flow, the net loss suggests that expenses and debt servicing costs are outpacing revenue growth. The outlook for the current fiscal year is not explicitly provided, but the negative net income indicates a challenging operating environment.

    Risk factors for the company include a high debt load, which could lead to increased financial distress if cash flows decline. The risk assessment indicates a low probability of dilution, but the company's capital structure and liquidity position suggest that it may need to raise additional capital in the future to maintain operations. The company's recent financial performance, including a net loss, may also affect its credit rating and access to financing.

    Recent events affecting the company include the reported net loss and the high level of debt. The company's financial statements indicate that it has a negative net cash position after subtracting total debt, which could signal financial stress and the need for strategic adjustments to improve liquidity and profitability.

    Key takeaways
    • The company has a highly leveraged capital structure with a debt-to-equity ratio of 7.66.
    • Profitability is weak, with a negative return on equity and return on assets.
    • The company's liquidity position is medium, with a current ratio of 0.75.
    • The company reported a net loss of 27,285,000,000 IDR, indicating financial stress.
    • The company's revenue is concentrated in the food and drug retailing segment, with no disclosed geographic diversification.
    • "margin_outlook_rationale": "The company's margin outlook is negative due to the reported net loss and weak profitability metrics.",

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 5

    Revenue grew 2.2% annually over four years, demonstrating consistent top-line expansion despite challenging market conditions.

    The company generated positive free cash flow of IDR 128.4 billion in the latest period, supporting liquidity needs.

    Long-term debt decreased from IDR 2.15 trillion in 2022 to IDR 1.56 trillion in the latest period, reducing leverage.

    Operating income turned positive in the latest period at IDR 26.1 billion, indicating improved operational efficiency compared to prior losses.

    Dilution risk is assessed as low, suggesting minimal threat to existing shareholder equity value from share issuance.

    BEAR CASE · 2

    The debt-to-equity ratio of 7.66 is significantly higher than the cohort median of 0.51, indicating excessive leverage.

    Credit risk is flagged as high, reflecting significant concerns regarding the company's ability to meet financial obligations.

    In focus — financials by report

    Annual
    ANNUALFiled 2023-03-06
    FY 2023 · Full-year highlights

    Revenue IDR 7.02T, +5,4% YoY; Operating income −208,9% YoY.

    RevenueIDR 7.02T+5,4 % YoY
    Operating income-IDR 210.94B−208,9 % YoY
    Net income-IDR 429.63B−27,3 % YoY
    Free cash flowIDR 40.53B−77,8 % YoY
    EPS
    Operating cash flowIDR 216.73B−47,4 % YoY
    Financials
    Income statement
    RevenueIDR 7.02T
    Gross profitIDR 1.28T
    Operating income-IDR 210.94B
    Net income-IDR 429.63B
    Margins
    Gross margin18.3%
    Operating margin-3.0%
    Net margin-6.1%
    FCF margin0.6%
    Balance sheet
    Total assetsIDR 3.78T
    Total liabilitiesIDR 3.62T
    Total equityIDR 165.98B
    Cash & equivalentsIDR 4.76B
    Long-term debtIDR 1.87T
    Cash flow
    Operating cash flowIDR 216.73B
    CapEx-IDR 18.13B
    Free cash flowIDR 40.53B
    SBC
    P&L flow · revenue → net income
    Revenue IDR 1.81TOperating costs IDR 1.80TFinance IDR 37.66BNet income IDR 27.29B
    Highlights
    • Revenue IDR 7.02T, +5,4% YoY
    • Operating income −208,9% YoY
    • Net income −27,3% YoY
    • Free cash flow −77,8% YoY
    • Net margin -6.1%

    Valuation FY

    Market price
    $52,00
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $201.76B
    Net cash
    -$1.55T
    Current ratio
    0.8
    Debt / equity
    7.7
    ROA
    -0.8%
    ROE
    -13.5%
    Cash conversion
    -634.0%
    CapEx / revenue
    -1.1%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin0,4 %Bottom quartile
    Net Margin-1,5 %Bottom quartile
    ROE-13,5 %Bottom quartile
    Capex / Rev-1,1 %Above median
    D/E7,66Bottom quartile
    Cash Conv-6,34Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • Matahari Putra Prima Tbk PT Market data — financials · 2026-05-28

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    MPPA.JKCanonical
    IDX (Jakarta) · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2023-03-06 17:07 UTCEARNINGSAnnual results — FY 2023 Revenue IDR 7017.53B · Net IDR -429.63B
    2022-03-31 20:51 UTCEARNINGSAnnual results — FY 2022 Revenue IDR 6655.22B · Net IDR -337.55B
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage